Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Somatostatinoma 2 Sarcoma 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasms, Plasma Cell 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Insulinoma 2 Glucagonoma 2 Gliosarcoma 2 Gastrinoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Islet Cell 2 Brain Neoplasms 2 von Hippel-Lindau Disease 1 Vipoma 1 Uterine Cervical Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Solitary Fibrous Tumor, Pleural 1 Primary Myelofibrosis 1 Pheochromocytoma 1

Interventions

lutetium Lu 177 dotatate 34 Everolimus 33 lanreotide 13 gallium Ga 68 dotatate 13 Temozolomide 13 Magnetic Resonance Spectroscopy 13 Nivolumab 12 pembrolizumab 11 Octreotide 11 Capecitabine 11 177Lu-octreotide, DOTA(0)-Tyr(3)- 10 cabozantinib 9 Positron Emission Tomography Computed Tomography 9 3-Iodobenzylguanidine 9 surufatinib 8 Sunitinib 8 Specimen Handling 7 Carboplatin 7 pasireotide 6 amino-acid, glucose, and electrolyte solution 6 90Y-octreotide, DOTA-Tyr(3)- 6 lenvatinib 5 Lutetium-177 5 Ipilimumab 5 Fluorodeoxyglucose F18 5 Etoposide 5 Cisplatin 5 Bevacizumab 5 telotristat ethyl 4 olaparib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neuroendocrine Tumors × vatalanib × Clear all

NCT00590343 2011-06-29

PTK787

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡